Assyro AI

Orange Book product · Brand (NDA)

SITAVIG

ACYCLOVIR

Brand (NDA)NDA 203791DISCN LIGAND PHARMS

At a glance

Apr 12, 2013

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 12, 2013

    13 yr 5 mo ago

  2. Today

  3. Patent 8791127 expires

    Listed drug product patent expiration.

    Mar 23, 2027

    in 9 mo

  4. Patent 8747896 expires

    Listed drug product patent expiration.

    Jun 03, 2027

    in 1 yr

  5. Patent 8592434 expires

    Listed drug product patent expiration.

    Jun 16, 2030

    in 4 yr 1 mo

Pharmaceutical detail

Active ingredient

ACYCLOVIR

Strength

50MG

Dosage form

TABLET

Route

BUCCAL

TE code

Not listed

Application

NDA 203791

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8791127Mar 23, 2027in 9 mo
ProductU-1460
8747896Jun 03, 2027in 1 yr
ProductU-1460
8592434Jun 16, 2030in 4 yr 1 mo
ProductU-1460
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.